Research and publication examining the prevention and treatment of dysphagia in patients who have received the LINX™ Reflux Management System.
A commonly reported adverse event captured after the implant of the LINX™ Reflux Management system is post-operative dysphagia. Although dysphagia is a known adverse event and included in the IFU, it continues to be a frequently reported after implantation of the LINX™ Reflux Management system. Dysphagia is also an adverse event frequently associated with explant of the device.
As such, Johnson & Johnson MedTech Surgery is interested in receiving proposals for research summarizing the best practices for both the prevention and treatment of dysphagia in patients who have received the LINX™ Management System.